Stephanie Ceman

Title: The Innovations of Stephanie Ceman

Introduction

Stephanie Ceman is a notable inventor based in Atlanta, GA. She has made significant contributions to the field of molecular biology, particularly in understanding fragile X syndrome and associated disorders. Her innovative work has led to the development of methods for identifying and modulating RNA transcripts involved in these conditions.

Latest Patents

Ceman holds a patent titled "Method and identification of downstream mRNA ligands to FMRP and their role in fragile X syndrome and associated disorders." This patent provides compositions and methods for identifying and/or modulating RNA transcripts and/or genes involved in fragile X syndrome and other associated disorders. In particular, her work has identified RNA targets for fragile X mental retardation protein (FMRP) through a novel monoclonal antibody to FMRP. Additionally, a consensus sequence for the RNA binding region has been established. The patent also includes arrays for identifying compounds, proteins, nucleotides, and other elements that modulate the RNA targets or associated genes. Furthermore, methods for modulating RNA targets are provided.

Career Highlights

Throughout her career, Ceman has worked at prestigious institutions such as Rockefeller University and Duke University. Her research has focused on the molecular mechanisms underlying fragile X syndrome, contributing to a better understanding of this genetic disorder.

Collaborations

Some of her notable coworkers include Stephen T. Warren and Victoria Brown-Kennerly. Their collaborative efforts have further advanced the research in the field of fragile X syndrome.

Conclusion

Stephanie Ceman's innovative work and patent contributions have significantly impacted the understanding of fragile X syndrome and its associated disorders. Her research continues to pave the way for future advancements in molecular biology and genetic research.